These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26300964)

  • 1. Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms.
    Pascu AM; Ifteni P; Teodorescu A; Burtea V; Correll CU
    Int J Ment Health Syst; 2015; 9():33. PubMed ID: 26300964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Huntington's Disease Gene in an Italian Cohort of Patients with Bipolar Disorder.
    Ferrari C; Capacci E; Bagnoli S; Ingannato A; Sorbi S; Nacmias B
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms.
    Pla P; Orvoen S; Saudou F; David DJ; Humbert S
    Front Behav Neurosci; 2014; 8():135. PubMed ID: 24795586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
    Nithianantharajah J; Hannan AJ
    Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
    Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
    Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
    Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
    J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's Disease in a Patient Misdiagnosed as Conversion Disorder.
    Nogueira JM; Franco AM; Mendes S; Valadas A; Semedo C; Jesus G
    Case Rep Psychiatry; 2018; 2018():3915657. PubMed ID: 29670796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling progression subtypes in people with Huntington's disease.
    Raschka T; Li Z; Gaßner H; Kohl Z; Jukic J; Marxreiter F; Fröhlich H
    EPMA J; 2024 Jun; 15(2):275-287. PubMed ID: 38841617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.
    Latimer CS; Flanagan ME; Cimino PJ; Jayadev S; Davis M; Hoffer ZS; Montine TJ; Gonzalez-Cuyar LF; Bird TD; Keene CD
    J Huntingtons Dis; 2017; 6(4):337-348. PubMed ID: 29036832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.
    Li HL; Li XY; Dong Y; Zhang YB; Cheng HR; Gan SR; Liu ZJ; Ni W; Burgunder JM; Yang XW; Wu ZY
    Aging Dis; 2019 Oct; 10(5):1003-1011. PubMed ID: 31595198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Advances for Huntington's Disease.
    Kumar A; Kumar V; Singh K; Kumar S; Kim YS; Lee YM; Kim JJ
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31940909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
    Savitt D; Jankovic J
    J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies.
    Irfan Z; Khanam S; Karmakar V; Firdous SM; El Khier BSIA; Khan I; Rehman MU; Khan A
    Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
    Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
    J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.